High-fat diet decreases cancellous bone mass but has no effect on cortical bone mass in the tibia in mice

Bone

Volumn 44, Issue 6, 2009, Pages 1097-1104

  Cao, Jay J ^a   Gregoire, Brian R ^a   Gao, Hongwei ^b  

^a GRAND FORKS HUMAN NUTRITION RESEARCH CENTER   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Bone; Bone marrow stromal osteoblastic cells; Fat; Micro CT; Obesity

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; ALKALINE PHOSPHATASE; OSTEOCALCIN; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW CELL; BONE MASS; BONE METABOLISM; BONE MINERALIZATION; BONE STRUCTURE; CANCELLOUS BONE; CONTROLLED STUDY; CORTICAL BONE; GENE EXPRESSION; LIPID DIET; MALE; MICRO-COMPUTED TOMOGRAPHY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OBESITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TIBIA;

ACID PHOSPHATASE; ALKALINE PHOSPHATASE; ANIMALS; BODY WEIGHT; BONE DENSITY; BONE MARROW CELLS; CELLS, CULTURED; DIETARY FATS; FEMUR; ISOENZYMES; MALE; MICE; MICE, INBRED C57BL; OSTEOBLASTS; POLYMERASE CHAIN REACTION; RANK LIGAND; STROMAL CELLS; TIBIA; X-RAY MICROTOMOGRAPHY;

EID: 67349252445     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2009.02.017     Document Type: Article

References (48)

1. Reid I.R., Ames R., Evans M.C., Sharpe S., Gamble G., France J.T., Lim T.M., and Cundy T.F. Determinants of total body and regional bone mineral density in normal postmenopausal women-a key role for fat mass. J. Clin. Endocrinol. Metab. 75 (1992) 45-51
2. Kopelman P.G. Obesity as a medical problem. Nature 404 (2000) 635-643
3. Villareal D.T., Apovian C.M., Kushner R.F., and Klein S. Obesity in older adults: technical review and position statement of the American Society for Nutrition and NAASO, the Obesity Society. Am. J. Clin. Nutr. 82 (2005) 923-934
4. Felson D.T., Zhang Y., Hannan M.T., and Anderson J.J. Effects of weight and body mass index on bone mineral density in men and women: the Framingham study. J. Bone Miner. Res. 8 (1993) 567-573
5. Ravn P., Cizza G., Bjarnason N.H., Thompson D., Daley M., Wasnich R.D., McClung M., Hosking D., Yates A.J., Christiansen C., and Early Postmenopausal Intervention Cohort (EPIC) study group. Low body mass index is an important risk factor for low bone mass and increased bone loss in early postmenopausal women. J. Bone Miner. Res. 14 (1999) 1622-1627
6. Robling A.G., Castillo A.B., and Turner C.H. Biomechanical and molecular regulation of bone remodeling. Annu. Rev. Biomed. Eng. 8 (2006) 455-498
7. Ehrlich P.J., and Lanyon L.E. Mechanical strain and bone cell function: a review. Osteoporos. Int. 13 (2002) 688-700
8. Bonewald L.F., and Johnson M.L. Osteocytes, mechanosensing and Wnt signaling. Bone 42 (2008) 606-615
9. Sawakami K., Robling A.G., Ai M., Pitner N.D., Liu D., Warden S.J., Li J., Maye P., Rowe D.W., Duncan R.L., Warman M.L., and Turner C.H. The Wnt co-receptor LRP5 is essential for skeletal mechanotransduction but not for the anabolic bone response to parathyroid hormone treatment. J. Biol. Chem. 281 (2006) 23698-23711
10. Zhao L.J., Jiang H., Papasian C.J., Maulik D., Drees B., Hamilton J., and Deng H.W. Correlation of obesity and osteoporosis: effect of fat mass on the determination of osteoporosis. J. Bone Miner. Res. 23 (2008) 17-29
11. Blum M., Harris S.S., Must A., Naumova E.N., Phillips S.M., Rand W.M., and Dawson-Hughes B. Leptin, body composition and bone mineral density in premenopausal women. Calcif. Tissue Int. 73 (2003) 27-32
12. Pollock N.K., Laing E.M., Baile C.A., Hamrick M.W., Hall D.B., and Lewis R.D. Is adiposity advantageous for bone strength? A peripheral quantitative computed tomography study in late adolescent females. Am. J. Clin. Nutr. 86 (2007) 1530-1538
13. David V., Martin A., Lafage-Proust M.H., Malaval L., Peyroche S., Jones D.B., Vico L., and Guignandon A. Mechanical loading down-regulates peroxisome proliferator-activated receptor gamma in bone marrow stromal cells and favors osteoblastogenesis at the expense of adipogenesis. Endocrinology 148 (2007) 2553-2562
14. Takada I., Suzawa M., Matsumoto K., and Kato S. Suppression of PPAR transactivation switches cell fate of bone marrow stem cells from adipocytes into osteoblasts. Ann. N. Y. Acad. Sci. 1116 (2007) 182-195
15. Hamrick M.W., Pennington C., Newton D., Xie D., and Isales C. Leptin deficiency produces contrasting phenotypes in bones of the limb and spine. Bone 34 (2004) 376-383
16. Li K.C., Zernicke R.F., Barnard R.J., and Li A.F. Effects of a high fat-sucrose diet on cortical bone morphology and biomechanics. Calcif. Tissue Int. 47 (1990) 308-313
17. Wohl G.R., Loehrke L., Watkins B.A., and Zernicke R.F. Effects of high-fat diet on mature bone mineral content, structure, and mechanical properties. Calcif. Tissue Int. 63 (1998) 74-79
18. Zernicke R.F., Salem G.J., Barnard R.J., and Schramm E. Long-term, high-fat-sucrose diet alters rat femoral neck and vertebral morphology, bone mineral content, and mechanical properties. Bone 16 (1995) 25-31
19. Reeves P.G., Nielsen F.H., and Fahey Jr. G.C. AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J. Nutr. 123 (1993) 1939-1951
20. Droke E.A., Hager K.A., Lerner M.R., Lightfoot S.A., Stoecker B.J., Brackett D.J., and Smith B.J. Soy isoflavones avert chronic inflammation-induced bone loss and vascular disease. J. Inflamm. (Lond). 4 (2007) 17
21. Lane N.E., Yao W., Nakamura M.C., Humphrey M.B., Kimmel D., Huang X., Sheppard D., Ross F.P., and Teitelbaum S.L. Mice lacking the integrin beta5 subunit have accelerated osteoclast maturation and increased activity in the estrogen-deficient state. J. Bone. Miner. Res. 20 (2005) 58-66
22. Halloran B.P., Ferguson V.L., Simske S.J., Burghardt A., Venton L.L., and Majumdar S. Changes in bone structure and mass with advancing age in the male C57BL/6J mouse. J. Bone. Miner. Res. 17 (2002) 1044-1050
23. Parfitt A.M., Drezner M.K., Glorieux F.H., Kanis J.A., Malluche H., Meunier P.J., Ott S.M., Recker R.R., and Report of the ASBMR Histomorphometry Nomenclature Committee. Bone histomorphometry: standardization of nomenclature, symbols, and units. J. Bone. Miner. Res. 2 (1987) 595-610
24. SAS Institute Inc. SAS/STAT User's Guide (2005), SAS Institute Inc., Cary, NC
25. Surwit R.S., Kuhn C.M., Cochrane C., McCubbin J.A., and Feinglos M.N. Diet-induced type II diabetes in C57BL/6J mice. Diabetes 37 (1988) 1163-1167
26. Collins S., Martin T.L., Surwit R.S., and Robidoux J. Genetic vulnerability to diet-induced obesity in the C57BL/6J mouse: physiological and molecular characteristics. Physiol. Behav. 81 (2004) 243-248
27. Sakata T., Halloran B.P., Elalieh H.Z., Munson S.J., Rudner L., Venton L., Ginzinger D., Rosen C.J., and Bikle D.D. Skeletal unloading induces resistance to insulin-like growth factor I on bone formation. Bone 32 (2003) 669-680
28. Kostenuik P.J., Halloran B.P., Morey-Holton E.R., and Bikle D.D. Skeletal unloading inhibits the in vitro proliferation and differentiation of rat osteoprogenitor cells. Am. J. Physiol. 273 (1997) E1133-E1139
29. Brahmabhatt V., Rho J., Bernardis L., Gillespie R., and Ziv I. The effects of dietary-induced obesity on the biomechanical properties of femora in male rats. Int. J. Obes. Relat. Metab. Disord. 22 (1998) 813-818
30. Smith E.E., Ferguson V.L., Simske S.J., Gayles E.C., and Pagliassotti M.J. Effects of high fat or high sucrose diets on rat femora mechanical and compositional properties. Biomed. Sci. Instrum. 36 (2000) 385-390
31. Brown J.L., Spicer M.T., and Spicer L.J. Effect of high-fat diet on body composition and hormone responses to glucose tolerance tests. Endocrine 19 (2002) 327-332
32. Scacchi M., Pincelli A.I., and Cavagnini F. Growth hormone in obesity. Int. J. Obes. Relat. Metab. Disord. 23 (1999) 260-271
33. Maor G., Rochwerger M., Segev Y., and Phillip M. Leptin acts as a growth factor on the chondrocytes of skeletal growth centers. J. Bone. Miner. Res. 17 (2002) 1034-1043
34. Atteh J.O., Leeson S., and Julian R.J. Effects of dietary levels and types of fat on performance and mineral metabolism of broiler chicks. Poult. Sci. 62 (1983) 2403-2411
35. Morgan E.F., Barnes G.L., and Einhorn T.A. The bone organ system: form and function. In: Marcus R., Feldman D., Nelson D.A., and Rosen C.J. (Eds). Osteoporosis. 3rd ed (2008), Elsevier Academic Press, Burlington, MA 3-25
36. Tremollieres F.A., Pouilles J.M., and Ribot C. Vertebral postmenopausal bone loss is reduced in overweight women: a longitudinal study in 155 early postmenopausal women. J. Clin. Endocrinol. Metab. 77 (1993) 683-686
37. Palacios C. The role of nutrients in bone health, from A to Z. Crit. Rev. Food. Sci. Nutr. 46 (2006) 621-628
38. Tortoriello D.V., McMinn J., and Chua S.C. Dietary-induced obesity and hypothalamic infertility in female DBA/2J mice. Endocrinology 145 (2004) 1238-1247
39. Relling D.P., Esberg L.B., Fang C.X., Johnson W.T., Murphy E.J., Carlson E.C., Saari J.T., and Ren J. High-fat diet-induced juvenile obesity leads to cardiomyocyte dysfunction and upregulation of Foxo3a transcription factor independent of lipotoxicity and apoptosis. J. Hypertens. 24 (2006) 549-561
40. Novack D.V., and Teitelbaum S.L. The osteoclast: friend or foe?. Annu. Rev. Pathol. 3 (2008) 457-484
41. Cao J., Venton L., Sakata T., and Halloran B.P. Expression of RANKL and OPG correlates with age-related bone loss in male C57BL/6 mice. J. Bone. Miner. Res. 18 (2003) 270-277
42. Shoelson S.E., Herrero L., and Naaz A. Obesity, inflammation, and insulin resistance. Gastroenterology 132 (2007) 2169-2180
43. Wellen K.E., and Hotamisligil G.S. Obesity-induced inflammatory changes in adipose tissue. J. Clin. Invest. 112 (2003) 1785-1788
44. Boyle W.J., Simonet W.S., and Lacey D.L. Osteoclast differentiation and activation. Nature 423 (2003) 337-342
45. Khosla S. Minireview: the OPG/RANKL/RANK system. Endocrinology 142 (2001) 5050-5055
46. Lacey D.L., Timms E., Tan H.L., Kelley M.J., Dunstan C.R., Burgess T., Elliott R., Colombero A., Elliott G., Scully S., Hsu H., Sullivan J., Hawkins N., Davy E., Capparelli C., Eli A., Qian Y.X., Kaufman S., Sarosi I., Shalhoub V., Senaldi G., Guo J., Delaney J., and Boyle W.J. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93 (1998) 165-176
47. Simonet W.S., Lacey D.L., Dunstan C.R., Kelley M., Chang M.S., Luthy R., Nguyen H.Q., Wooden S., Bennett L., Boone T., Shimamoto G., DeRose M., Elliott R., Colombero A., Tan H.L., Trail G., Sullivan J., Davy E., Bucay N., Renshaw-Gegg L., Hughes T.M., Hill D., Pattison W., Campbell P., Sander S., Van G., Tarpley J., Derby P., Lee R., and Boyle W.J. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 89 (1997) 309-319
48. Kong Y.Y., Yoshida H., Sarosi I., Tan H.L., Timms E., Capparelli C., Morony S., Oliveira-dos-Santos A.J., Van G., Itie A., Khoo W., Wakeham A., Dunstan C.R., Lacey D.L., Mak T.W., Boyle W.J., and Penninger J.M. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 397 (1999) 315-323